{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:45:45Z","timestamp":1787507145078,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,8]]},"DOI":"10.7759\/cureus.103206","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:34:48Z","timestamp":1770564888000},"source":"Crossref","is-referenced-by-count":1,"title":["Gut-Derived Metabolites and Cognitive Health: Roles of Short-Chain Fatty Acids and Trimethylamine N-oxide"],"prefix":"10.7759","author":[{"given":"Dharmendra Kumar","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2015.1039691","article-title":"Microbiota and the control of blood-tissue barriers","volume":"3","author":"Al-Asmakh M","year":"2015","unstructured":"Al-Asmakh M, Hedin L. Microbiota and the control of blood-tissue barriers. Tissue Barriers. 2015, 3:e1039691. 10.1080\/21688370.2015.1039691","journal-title":"Tissue Barriers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102659","article-title":"Gut microbiota in Alzheimer's disease: understanding molecular pathways and potential therapeutic perspectives","volume":"104","author":"Lista S","year":"2025","unstructured":"Lista S, Munaf\u00f2 A, Caraci F, et al.. Gut microbiota in Alzheimer's disease: understanding molecular pathways and potential therapeutic perspectives. Ageing Res Rev. 2025, 104:102659. 10.1016\/j.arr.2025.102659","journal-title":"Ageing Res Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01146-2","article-title":"Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies","volume":"56","author":"Seo DO","year":"2024","unstructured":"Seo DO, Holtzman DM. Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies. Exp Mol Med. 2024, 56:86-94. 10.1038\/s12276-023-01146-2","journal-title":"Exp Mol Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva YP","year":"2020","unstructured":"Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne). 2020, 11:25. 10.3389\/fendo.2020.00025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.611014","article-title":"Roles of gut microbiota in the regulation of hippocampal plasticity, inflammation, and hippocampus-dependent behaviors","volume":"10","author":"Tang W","year":"2020","unstructured":"Tang W, Meng Z, Li N, Liu Y, Li L, Chen D, Yang Y. Roles of gut microbiota in the regulation of hippocampal plasticity, inflammation, and hippocampus-dependent behaviors. Front Cell Infect Microbiol. 2020, 10:611014. 10.3389\/fcimb.2020.611014","journal-title":"Front Cell Infect Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101398","article-title":"Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target","volume":"10","author":"Janeiro MH","year":"2018","unstructured":"Janeiro MH, Ram\u00edrez MJ, Milagro FI, Mart\u00ednez JA, Solas M. Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target. Nutrients. 2018, 10:1398. 10.3390\/nu10101398","journal-title":"Nutrients"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040657","article-title":"Mechanisms of blood-brain barrier protection by microbiota-derived short-chain fatty acids","volume":"12","author":"Fock E","year":"2023","unstructured":"Fock E, Parnova R. Mechanisms of blood-brain barrier protection by microbiota-derived short-chain fatty acids. Cells. 2023, 12:657. 10.3390\/cells12040657","journal-title":"Cells"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/nu9101053","article-title":"The gut microbial metabolite trimethylamine-N-oxide is present in human cerebrospinal fluid","volume":"9","author":"Del Rio D","year":"2017","unstructured":"Del Rio D, Zimetti F, Caffarra P, et al.. The gut microbial metabolite trimethylamine-N-oxide is present in human cerebrospinal fluid. Nutrients. 2017, 9:1053. 10.3390\/nu9101053","journal-title":"Nutrients"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.17179\/excli2020-2763","article-title":"Assessment of trimethylamine-N-oxide at the blood-cerebrospinal fluid barrier: results from 290 lumbar punctures","volume":"19","author":"Enko D","year":"2020","unstructured":"Enko D, Zelzer S, Niedrist T, et al.. Assessment of trimethylamine-N-oxide at the blood-cerebrospinal fluid barrier: results from 290 lumbar punctures. EXCLI J. 2020, 19:1275-81. 10.17179\/excli2020-2763","journal-title":"EXCLI J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger MM","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, et al.. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat Disord. 2016, 32:66-72. 10.1016\/j.parkreldis.2016.08.019","journal-title":"Parkinsonism Relat Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25982","article-title":"Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics","volume":"89","author":"Tan AH","year":"2021","unstructured":"Tan AH, Chong CW, Lim SY, et al.. Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics. Ann Neurol. 2021, 89:546-59. 10.1002\/ana.25982","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease","volume":"98","author":"Chen SJ","year":"2022","unstructured":"Chen SJ, Chen CC, Liao HY, et al.. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology. 2022, 98:e848-58. 10.1212\/WNL.0000000000013225","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70877","article-title":"Fecal short-chain fatty acids vary by sex and amyloid status","volume":"21","author":"Kuehn JF","year":"2025","unstructured":"Kuehn JF, Zhang Q, Heston MB, et al.. Fecal short-chain fatty acids vary by sex and amyloid status. Alzheimers Dement. 2025, 21:e70877. 10.1002\/alz.70877","journal-title":"Alzheimers Dement"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.08.032","article-title":"Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment","volume":"47","author":"Nagpal R","year":"2019","unstructured":"Nagpal R, Neth BJ, Wang S, Craft S, Yadav H. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019, 47:529-42. 10.1016\/j.ebiom.2019.08.032","journal-title":"EBioMedicine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0451-2","article-title":"The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease","volume":"10","author":"Vogt NM","year":"2018","unstructured":"Vogt NM, Romano KA, Darst BF, et al.. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease. Alzheimers Res Ther. 2018, 10:124. 10.1186\/s13195-018-0451-2","journal-title":"Alzheimers Res Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1039\/d2fo02021a","article-title":"Increased plasma trimethylamine-N-oxide levels are associated with mild cognitive impairment in high cardiovascular risk elderly population","volume":"13","author":"Buawangpong N","year":"2022","unstructured":"Buawangpong N, Pinyopornpanish K, Phrommintikul A, Chindapan N, Devahastin S, Chattipakorn N, Chattipakorn SC. Increased plasma trimethylamine-N-oxide levels are associated with mild cognitive impairment in high cardiovascular risk elderly population. Food Funct. 2022, 13:10013-22. 10.1039\/d2fo02021a","journal-title":"Food Funct"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01480-1","article-title":"Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia","volume":"16","author":"Yaqub A","year":"2024","unstructured":"Yaqub A, Vojinovic D, Vernooij MW, et al.. Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia. Alzheimers Res Ther. 2024, 16:113. 10.1186\/s13195-024-01480-1","journal-title":"Alzheimers Res Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12768","article-title":"Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice","volume":"17","author":"Li D","year":"2018","unstructured":"Li D, Ke Y, Zhan R, et al.. Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. Aging Cell. 2018, 17:e12768. 10.1111\/acel.12768","journal-title":"Aging Cell"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102352","article-title":"Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer's disease","volume":"11","author":"Gao Q","year":"2019","unstructured":"Gao Q, Wang Y, Wang X, Fu S, Zhang X, Wang RT, Zhang X. Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer's disease. Aging (Albany NY). 2019, 11:8642-63. 10.18632\/aging.102352","journal-title":"Aging (Albany NY)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223650","article-title":"Higher circulating trimethylamine N-oxide aggravates cognitive impairment probably via downregulating hippocampal SIRT1 in vascular dementia rats","volume":"11","author":"Deng Y","year":"2022","unstructured":"Deng Y, Zou J, Hong Y, et al.. Higher circulating trimethylamine N-oxide aggravates cognitive impairment probably via downregulating hippocampal SIRT1 in vascular dementia rats. Cells. 2022, 11:3650. 10.3390\/cells11223650","journal-title":"Cells"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190120","article-title":"Sodium butyrate reduces brain amyloid-\u03b2 levels and improves cognitive memory performance in an Alzheimer's disease transgenic mouse model at an early disease stage","volume":"74","author":"Fernando WM","year":"2020","unstructured":"Fernando WM, Martins IJ, Morici M, Bharadwaj P, Rainey-Smith SR, Lim WL, Martins RN. Sodium butyrate reduces brain amyloid-\u03b2 levels and improves cognitive memory performance in an Alzheimer's disease transgenic mouse model at an early disease stage. J Alzheimers Dis. 2020, 74:91-9. 10.3233\/JAD-190120","journal-title":"J Alzheimers Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111376","article-title":"Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease","volume":"150","author":"Hou Y","year":"2021","unstructured":"Hou Y, Li X, Liu C, Zhang M, Zhang X, Ge S, Zhao L. Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease. Exp Gerontol. 2021, 150:111376. 10.1016\/j.exger.2021.111376","journal-title":"Exp Gerontol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626894","article-title":"The neuroprotective effect of short chain fatty acids against sepsis-associated encephalopathy in mice","volume":"12","author":"Liu J","year":"2021","unstructured":"Liu J, Jin Y, Ye Y, et al.. The neuroprotective effect of short chain fatty acids against sepsis-associated encephalopathy in mice. Front Immunol. 2021, 12:626894. 10.3389\/fimmu.2021.626894","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02474-7","article-title":"Engineered butyrate-producing yeasts mitigate Alzheimer-associated phenotypes","volume":"10","author":"Zhang B","year":"2025","unstructured":"Zhang B, Sun Z, Song W, Huang H, Wu Y. Engineered butyrate-producing yeasts mitigate Alzheimer-associated phenotypes. Signal Transduct Target Ther. 2025, 10:369. 10.1038\/s41392-025-02474-7","journal-title":"Signal Transduct Target Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1465457","article-title":"Association of trimethylamine oxide and its precursors with cognitive impairment: a systematic review and meta-analysis","volume":"16","author":"Long C","year":"2024","unstructured":"Long C, Li Z, Feng H, Jiang Y, Pu Y, Tao J, Yue R. Association of trimethylamine oxide and its precursors with cognitive impairment: a systematic review and meta-analysis. Front Aging Neurosci. 2024, 16:1465457. 10.3389\/fnagi.2024.1465457","journal-title":"Front Aging Neurosci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.20000","article-title":"Association between levels of trimethylamine N-oxide and cognitive dysfunction: a systematic review and meta-analysis","volume":"13","author":"Ren Z","year":"2025","unstructured":"Ren Z, Mo L. Association between levels of trimethylamine N-oxide and cognitive dysfunction: a systematic review and meta-analysis. PeerJ. 2025, 13:e20000. 10.7717\/peerj.20000","journal-title":"PeerJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462356-gut-derived-metabolites-and-cognitive-health-roles-of-short-chain-fatty-acids-and-trimethylamine-n-oxide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:34:49Z","timestamp":1770564889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462356-gut-derived-metabolites-and-cognitive-health-roles-of-short-chain-fatty-acids-and-trimethylamine-n-oxide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.103206","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,8]]}}}